University of Tennessee, Knoxville

TRACE: Tennessee Research and Creative
Exchange
Masters Theses

Graduate School

5-2010

Developing Chitosan-based Biomaterials for Brain Repair and
Neuroprosthetics
Zheng Cao
Department of Materials Science and Engineering, UTK, zcao1@utk.edu

Follow this and additional works at: https://trace.tennessee.edu/utk_gradthes
Part of the Bioelectrical and Neuroengineering Commons, Biomaterials Commons, Other
Neuroscience and Neurobiology Commons, and the Polymer and Organic Materials Commons

Recommended Citation
Cao, Zheng, "Developing Chitosan-based Biomaterials for Brain Repair and Neuroprosthetics. " Master's
Thesis, University of Tennessee, 2010.
https://trace.tennessee.edu/utk_gradthes/609

This Thesis is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and
Creative Exchange. It has been accepted for inclusion in Masters Theses by an authorized administrator of TRACE:
Tennessee Research and Creative Exchange. For more information, please contact trace@utk.edu.

To the Graduate Council:
I am submitting herewith a thesis written by Zheng Cao entitled "Developing Chitosan-based
Biomaterials for Brain Repair and Neuroprosthetics." I have examined the final electronic copy of
this thesis for form and content and recommend that it be accepted in partial fulfillment of the
requirements for the degree of Master of Science, with a major in Polymer Engineering.
Wei He, Major Professor
We have read this thesis and recommend its acceptance:
Roberto S. Benson, Kevin M. Kit
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)

To the Graduate Council:
I am submitting herewith a thesis written by Zheng Cao entitled “Developing Chitosanbased Biomaterials for Brain Repair and Neuroprosthetics”. I have examined the final
electronic copy of this thesis for form and content, and recommend that it be accepted in
partial fulfillment of the requirements for the degree of Master of Science, with a major
in Polymer Engineering.
Wei He

We have read this thesis
and recommend its acceptance:

Roberto S. Benson

Kevin M. Kit

Accepted for the Council:
Carolyn R. Hodges
Vice Provost and
Dean of the Graduate School

Developing Chitosan-based Biomaterials for Brain
Repair and Neuroprosthetics

A Thesis
Presented for the
Master of Science Degree
The University of Tennessee, Knoxville

Zheng Cao
May 2010

Copyright © 2010 by Zheng Cao
All rights reserved.

ii

ACKNOWLEDGEMENTS
I would like to express my sincere thanks to my advisor, Dr. Wei He, for her
guidance and support throughout my graduate studies. I gratefully acknowledge Dr.
Roberto S. Benson and Dr. Kevin M. Kit for serving on my committee and mentoring me
in the field of polymer engineering. I would like to thank Dr. Judy Grizzle, Dr. John
Dunlap, Gregory Jones, Dr. Federico Harte, Dr. Michael Smith, Dr. Svetlana Zivanovic,
Dr. Mingjun Zhang, and their students for the generous support on my research. I also
want to thank my fellow labmates, Yu Cao, Jonathan Page, and Kaan Serpersu for being
great helpers in research and friends in daily life. Finally, to my family and friends,
without your understanding and support none of this would have been possible.

iii

ABSTRACT
Chitosan is widely investigated for biomedical applications due to its excellent
properties, such as biocompatibility, biodegradability, bioadhesivity, antibacterial, etc. In
the field of neural engineering, it has been extensively studied in forms of film and
hydrogel, and has been used as scaffolds for nerve regeneration in the peripheral nervous
system and spinal cord. One of the main issues in neural engineering is the incapability of
neuron to attach on biomaterials. The present study, from a new aspect, aims to take
advantage of the bio-adhesive property of chitosan to develop chitosan-based materials
for neural engineering, specifically in the fields of brain repair and neuroprosthetics.
Neuronal responses to the developed biomaterials will also be investigated and discussed.
In the first part of this study (Chapter II), chitosan was blended with a wellstudied hydrogel material (agarose) to form a simply prepared hydrogel system. The
stiffness of the agarose gel was maintained despite the inclusion of chitosan. The
structure of the blended hydrogels was characterized by light microscopy and scanning
electron microscopy. In vitro cell studies revealed the capability of chitosan to promote
neuron adhesion. The concentration of chitosan in the hydrogel had great influence on
neurite extension. An optimum range of chitosan concentration in agarose hydrogel, to
enhance neuron attachment and neurite extension, was identified based on the results. A
“steric hindrance” effect of chitosan was proposed, which explains the origin of the
morphological differences of neurons in the blended gels as well as the influence of the
physical environment on neuron adhesion and neurite outgrowth. This chitosan-agarose
(C-A) hydrogel system and its multi-functionality allow for applications of simply
prepared agarose-based hydrogels for brain tissue repair.
In the second part of this study (Chapter III), chitosan was blended with graphene
to form a series of graphene-chitosan (G-C) nanocomposites for potential neural interface
applications. Both substrate-supported coatings and free standing films could be prepared
by air evaporation of precursor solutions. The electrical conductivity of graphene was
maintained after the addition of chitosan, which is non-conductive. The surface
characteristic of the films was sensitively dependent on film composition, and in turn,
iv

influenced neuron adhesion and neurite extension. Biological studies showed good
cytocompatibility of graphene for both fibroblast and neuron. Good cell-substrate
interactions between neurons and G-C nanocomposites were found on samples with
appropriate compositions. The results suggest this unique nanocomposite system may be
a promising substrate material used for the fabrication of implantable neural electrodes.
Overall, these studies confirmed the bio-adhesive property of chitosan. More
importantly, the developed chitosan-based materials also have great potential in the fields
of neural tissue engineering and neuroprosthetics.
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CHAPTER I
INTRODUCTION
1.1 Chitosan
Chitosan is a naturally occurring linear polysaccharide derived from chitin by
deacetylation of the N-acetyl-glucosamine residues under alkaline conditions or by enzymatic
hydrolysis in the presence of a chitin deacetylase.1 It is widely investigated for numerous
applications in the life sciences, including cosmetics, dietetics, pharmacology, and biomaterials.2
The chemical structure of chitosan largely determines its physical properties and applications. In
this section, the structure-properties relationship of chitosan in solutions will be briefly
introduced and discussed. Its applications in biomedical fields will then be elucidated.
1.1.1 Structure-Properties Relationship
Fig. 1.1 shows the chemical structure of chitosan. Because the temperatures of glass
transition and melting of chitosan are higher than its temperature of thermal decomposition, the
fabrication of chitosan is necessarily processed from solutions.2 Therefore, the most important
physical state for this polymer is solution. When studying solutions of chitosan, one of the key
parameters need to be considered is the degree of deacetylation (DDA), which distinguishes
chitosan from chitin. Molecular weight (MW) also plays critical roles for the properties of
chitosan in solutions.
1.1.1.1 Role of DDA
When DDA is higher than 40%, the polymer is soluble in dilute acidic solutions and is
defined as chitosan. This behavior is associated to the fact that the protonated amine groups of
glucosamine residues in acidic solutions interrupt the intrachain hydrogen bonds and make
solvent/polymer interactions more favorable.2 The value of the intrinsic pKa of chitosan is found
to be close to 6.5 when DDA is higher than 75%. That is, chitosan with DDA value higher than
75% is soluble in a solution with a pH value lower than 6.5, ignoring the effects from MW. The
relation between DDA and pKa of chitosan is quite complicated and requires a good
understanding of polymer science. Readers are encouraged to refer to the extensive work from
Sorlier et al. for more details.3 In this study, we are mainly concerned about the fact that a certain
1

Figure 1.1 Chemical structure of chitosan.
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amount of acid is required to solubilize chitosan in water, which is the most preferred solvent for
biomedical applications.
1.1.1.2 Role of MW
Thermodynamics suggests a decreased solubility of neutral polymers with an increase of
MW.4 In the case of chitosan, the possibility of intrachain association by hydrogen bonding plays
an additional role.2 When MW increases, aggregation between polymer chains becomes
favorable and the ionic strength becomes sufficiently high to favor the condensation of the
counterions. In addition to the intrachain association, an increase in MW always results in an
increase in viscosity of the solution. Therefore, it is often difficult to prepare chitosan solutions
with a concentration above 2-3 wt%. Furthermore, decreasing the MW could potentially increase
the concentration of the solution and improve the solubility of the polymer.
1.1.2 Biomedical Applications
Chitosan has been extensively studied as a biomaterial due to its excellent properties,
such as biocompatibility and biodegradability. For biomedical applications, it can be fabricated
into a variety of forms, including hydrogels, films, fibers, sponges, and micro- / nano-particles.2
Tissue scaffold is one of the most important applications of chitosan. By crosslinking
chitosan with glycerophosphate, Chenite et al. successfully prepared thermally sensitive neutral
chitosan solutions based on chitosan/polyol salts.5 The solutions can gel at physiological
temperature, and are able to deliver biologically active growth factors in vivo and serve as an
encapsulating matrix for living chondrocytes for tissue engineering applications. Subsequent
works using similar techniques have also been able to achieve a thermoresponsive system.6-9 In
the form of film, chitosan can be fabricated into conduit and used as a tissue scaffold.10 Artificial
poly(glycolic acid)-chitosan tube coated with recombinant L1-Fc promotes axonal regeneration
and remyelination, and has been shown capable of guiding nerve regeneration.11
Drug/protein/gene delivery is an important domain where chitosan micro-/nano-particles
are extensively employed. The positively charged chitosan chains can be easily complexed with
negatively charged DNAs and proteins.12 A simple precipitation process to prepare chitosan
microparticles without using any organic solvent was developed by Berthold et al.13 By simply
3

adding sodium sulfate (precipitant) into chitosan solution, the authors successfully prepared
chitosan microparticles with size around 1 μm. The drug release behavior of the microparticles
was tested in vitro using side-by-side diffusion cells and up to 30.5% loading was achieved with
prednisolone sodium phosphate. The most widely used precipitant for the formation of chitosan
nanoparticles is tripolyphosphate (TPP).12, 14, 15 Typically, a size ranging from 100 nm to 250 nm
is suitable for the delivery of gene or protein macromolecules. In order to fabricate chitosan
nanoparticles with predetermined properties, variations in chitosan molecular weight, chitosan
concentration, the weight ratio of chitosan to TPP, and solution pH value were examined
systematically for their effects on the particle size, intensity of surface charge, and tendency of
particle aggregation.12 The authors also examined the particle morphology using transmission
electron microscope (TEM) and confirmed a semicrystallization mechanism during the particle
formation and growth, which could bear important implications on gene/protein encapsulation
and release mechanisms.
Other biomedical applications of chitosan include surface modification, dialysis
membrane, sutures, etc.1 Table 1.1 summarizes the main applications of chitosan in the field of
biomaterials. Table 1.2 lists the important properties of chitosan related to biomedical
applications.

1.2 Neural Engineering
Neural engineering is a discipline that uses engineering techniques to understand, repair,
replace, enhance, or treat the diseases of nervous systems. Due to its biological and engineering
nature, many other disciplines are involved in its development, such as computational
neuroscience, experimental neuroscience, clinical neurology, electrical engineering and signal
processing, robotics, cybernetics, computer engineering, neural tissue engineering, materials
science, and nanotechnology.16 In the present study, we will mainly focus on the two major
domains in neural engineering: neural tissue engineering and neuroprosthetics. For tissue
engineering, our work specifically aims to address problems encountered in brain repair.
Traumatic brain injury (TBI) occurs when an external physical insult causes damages in
the brain. Because the injury is an on-going process, the primary damage could lead to a cascade
4

Table 1.1 Main applications of chitosan as biomaterials.1

Form

Application

Route of delivery/properties

Beads

Drug delivery
Enzyme immobilization

Oral

Microspheres

Oral, implantable, ocular, injectable

Coatings

Surface modification
Textile finishes

Chitosan increases mucoadhesivity of alginate capsules

Fibers

Medical textiles
Sutures

Nano-fibers

Guided bone regeneration
Scaffold for nerve tissue regeneration

Films

Wound care
Dialysis membrane

Powder

Adsorbent for pharmaceutical and medical devices
Surgical glove powder
Enzyme immobilization

Sponge

Mucosomal haemostatic dressing
Wound dressing
Drug delivery
Enzyme entrapment

Shaped
objects

Orthopaedics
Contact lenses

Solutions

Cosmetics
Bacteriostatic agent
Haemostatic agent
Anticoagulants
Anti-tumour agent

Gels

Delivery vehicle
Implants, coatings
Tissue engineering

Tablets

Compressed diluent
Disintegrating agent

Capsules

Delivery vehicle

Biodegradable

Moisture holding
Oral, nasal
Complex formation – gene delivery

Oral, buccal
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Table 1.2 Main properties of chitosan in biomedical applications.1

Properties
Biodegradability

Antibacterial

Renewable

Biocompatibility

Immunoadjuvant

Absorption promotes

Bioadhesivity

Antithrombogenic

Non-toxicity

Polycationic substance

Film forming

Non-allergenic

Antifungal

Hydrating agent

Anticholesteremic agent
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of deleterious events that can affect cell body and axonal function, resulting in continued
dysfunction and prolonged degeneration. Therefore, patients often suffer not only from the
immediate post-injury complications, but also the long-term problems associated with TBI, such
as Parkinson’s disease, Alzheimer’s diseases, post-traumatic dementia, etc.17 Fig. 1.2 shows the
events following TBI, involving a dynamic interplay between events promoting neural repair and
regeneration, and those of damage and inhibition.18 A better understanding of the mechanisms on
both sides of the response can aid in the development of more effective clinical treatments for
TBI. Each year, there are about 1.4 million people in the United States experience a TBI.17 As
one of the leading causes of death and disability, TBI poses a staggering financial burden to the
society, with an estimated expense of over $56 billion per year for medical care. Therefore, it is
urgent to develop clinically effective treatments to alleviate the pains of both patients and the
society.
1.2.1 Neural Tissue Engineering
The main on-going researches for neuroprotection and neuroregeneration in injured
central nervous system (CNS) include tissue scaffold, cell transplantation, and drug delivery.19
Fig. 1.3 shows a scheme of the combination of these three approaches applied in brain repair. An
artificial tissue scaffold can be implanted into the damaged region in the brain tissue, serving as a
structural support to the surrounding tissue to minimize secondary cellular degeneration. Both
neural stem cells and drugs can be delivered by the scaffold. Patient’s neurons from the adjacent
parenchyma can also infiltrate the scaffold, which potentially promotes local tissue regeneration.
Because the scaffold is the platform for the delivery of cell and drug as well as neuron
regeneration, its properties are critical to achieve all of these functions. The scaffold should
provide a friendly environment for both resident neurons and implanted neurons by mimicking
some of the features of the natural extracellular matrix (ECM) in the neural tissue. It should be
neuron-adhesive to offer anchorage points that allow neuron adhesion and neurite outgrowth. It
should be permissive, allowing cell migration and tissue remodeling as well as the diffusion of
nutrients, metabolites, and soluble factors. The mechanical properties should match the brain
tissue, because study has shown the mechanical properties of biomaterials are critical for neuron
adhesion and neurite outgrowth.20 Biodegradability is favored for brain repair since no foreign
7

Figure 1.2 Schematic of events following traumatic brain injury (TBI): (blue boxes) damage and
inhibition of regeneration; (orange boxes) permissive and reparative mechanisms. A better understanding
of the mechanisms on both sides of the response can aid in the development of more effective clinical
treatments for traumatic injury to the CNS.18
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Delivered drug

Figure 1.3 Combination of tissue scaffold, cell transplantation and drug delivery for the repair of
damaged brain tissue. Adapted from reference Nature Review Neuroscience 10 (2009) 682-692.19
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substance will remain in the injury site once new tissues have formed in place. When being used
for drug delivery, the chemical and structural properties of the scaffold also need to be
optimized.
Hydrogels have been favored as tissue scaffold materials for their excellent properties.
The porous structure allows for infiltration of cells as well as the diffusion of drugs, gases,
nutrients, and waste products. The mechanical properties of hydrogels can be tuned by changing
the density of the crosslinking points, allowing low interfacial tensions between the scaffold and
human tissue. Furthermore, most hydrogels are degradable by enzymes present in the human
body, a desirable feature for brain repair.
Currently, hydrogels based on both natural (e.g., agarose, alginate, hyaluronan, etc.) and
synthetic (e.g., polyethylene glycol, poly(2-hydroxyethyl methacrylate), etc.) polymers are being
studied for neural engineering.21 One of the great limitations of these hydrogels is the need for
chemically incorporation of neuron-adhesive protein or peptide sequences due to their intrinsic
non-adhesive nature.22-24 Potential problems associated with chemical functionalization include:
(1) complex, costly and time-consuming process and (2) introduction of toxic organic solvents
during preparation that could be harmful for cellular growth. A simply prepared neuron-adhesive
hydrogel system without any chemical reaction would have great potential for neural tissue
engineering.
1.2.2 Neuroprosthetics
Unlike neural tissue engineering, which aims to protect and repair the injured tissue right
after the injury, neuroprosthetics are more like a “make-up” approach for a damaged nervous
system. It generally involves artificial devices to replace the function of impaired nervous
systems or sensory organs, such as restoring sights, hearing, movement, ability to communicate,
and even cognitive functions. The most widely used neuroprosthetic device is the cochlear
implant, which has been benefiting approximately 100,000 people worldwide as of 2006.25
Nowadays, chronically implanted neural electrodes recording signals from individual
neurons in human brain rekindle the hope of numerous patients suffering from full or partial
paralysis.26-28 Fig. 1.4 is a scheme showing the principle and potential applications of this kind of
device as well as the greatest challenges it faces currently. The neural electrodes, which can be in
10

Figure 1.4 Principles, applications and challenge of implantable neural electrodes.
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the form of metal wires or silicon and/or polymer shanks, are inserted into the brain cortex. If
functioning properly, the device can record the action potentials from the adjacent healthy
neurons. The collected signals are then transported to an external device, which typically is a
computer. The signals are processed, analyzed, and translated into commands. Then the
commands are utilized for controlling prosthetic devices, such as artificial arms, wheelchairs,
entertainment media, etc.
To date, several different multichannel recording electrode arrays have been designed
(Fig. 1.5).29-32 Most of them are fabricated from silicon taking advantage of the well-established
manufacturing process used in the semiconductor industry. Although the present implant systems
are well studied and perform as intended in short-term investigations, the greatest challenge of
the implants for clinical applications is its unreliable long-term performance.33 For instance, a
40% drop in the number of functional electrodes between 1 and 18 months was reported in the
study of Nicolelis et al.29 Similar observations have also been reported by other researchers.31, 34
Scientific studies suggest that the long-term performance problem is likely due to the
tissue response that the brain mounts against implanted electrodes.33 Several factors could
potentially contribute to the tissue response: (1) the mechanical trauma of insertion severing
capillaries, extracellular matrix, glial and neuronal cell processes; (2) the long-term inflammation
induced by the presence of the insoluble device; (3) the biocompatibility of the implanted
substrate material; and (4) the chronic micromotion-induced mechanical strains around the
implant interface. Eventually, the response results in the formation of an encapsulating glial scar
(Fig. 1.4) and a poor integration between the device and neural tissue.
Current approaches to minimize this tissue response include: (1) advanced neural probe
design, (2) surface modification of the existing implanted substrate, and (3) drug delivery locally
or systemically to therapeutically influence the cellular responses.33 A recent study from Dr.
Kipke’s group at the University of Michigan reported the fabrication of a parylene-based probe
with a thick shank and an integrated thin lateral platform with recording site.35 Biological studies
showed a reduced tissue encapsulation and higher neuronal density around the recording site
compared with the thick shank. It is suggested that the electrode performance can be maintained
in long-term by attracting and preserving neurons near the recording sites. A variety of materials
12

Figure 1.5 Designs of multichannel recording electrode arrays: (a-b) wire electrode arrays;29 (c) a single
electrode shank with multiple electrode sites;30 (d) Utah Electrode Array formed from a single block of
silicon;31 (e-f) multiple planar arrays of Michigan Electrodes are stacked together to create a threedimensional array.32
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have been used to modify the substrate surface, such as cell adhesion small polypeptides/proteins
(e.g., poly-L-lysine and laminin36) and oligopeptides (e.g., Arg-Gly-Asp (RGD) and Tyr-Ile-GlySer-Arg (YIGSR)37). Conductive polymer coatings, including polypyrrole and poly(3,4ethylenedioxythiophene), have also been studied for their ability to overcome the encapsulation
barrier and improve electrical characteristics by increasing electrode sensitivity.38-41 Drug release
is another option that could potentially promote neuronal survival and growth. On the one hand,
growth factors and chemoattractants can be used to attract neuron migration towards the
electrodes and facilitate neuron regeneration.42 On the other hand, immunosuppressant molecules
such as Dexamethasone43 and Cyclosporin-A44 can be used to reduce the initial immune response
and potentially the glial scar formation. Other drugs like minocycline45-47 also show their
capability to protect neurons against excitotoxicity by inhibiting activation and proliferation of
microglia. Although moderate success has been achieved by some of the methods in reducing the
tissue response, devices with long-term reliable performance are still not clinically applicable.
Simply modifying the surface of existing substrate materials will not be able to eliminate
the micromotion induced by the mechanical mismatch between the tissue and electrodes, which
is believed to profoundly contribute to the chronic immune response.33 Recently, the neural
interface community is focusing on exploring brand new implantable materials that can be used
for neural electrodes with reliable chronic performance.48 The new materials should be flexible
with low interfacial tension with human brain and ability to change its shape along with tissue
deformation. Electrical conductivity is required for the normal function of neural recording
electrodes. The substrate should be neuro-adhesive to ensure good neuron-substrate interactions.
In addition, good biocompatibility and biostability are always required for implantable
biomaterials intended for chronic use. Developing substrate materials meeting all of these
criteria is still a major challenge in the field of neuroprosthetics.

1.3 Rationale and Objectives
Chitosan has been studied for nerve tissue regeneration. Until now, most of the works are
focusing on its film and scaffold forms for nerve regeneration in the peripheral nervous system
and spinal cord.6, 10, 49 The present study, from another aspect, aims to take advantage of the bio-
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adhesive property of chitosan and investigate its potential applications in neural engineering,
specifically in the fields of brain repair and neuroprosthetics (brain-computer interface).
One of the main issues in neural engineering is the poor ability of neuronal cells to attach
and grow on most biomaterials. A variety of strategies have been developed to stimulate neuron
adhesion and growth.50 Scientific studies have shown that chemical factors (e.g., ECM proteins
and certain peptide sequences51,

52

), topographical features of biomaterials,53-55 and substrate

stiffness play critical roles in neuron adhesion, growth, and tissue remodeling. Previous studies
have shown the ability of chitosan to facilitate attachment of dorsal root ganglion (DRG),10, 56
keratinocytes,57 fibroblasts,57 and Schwann cells,58 indicating a nonspecific interaction between
cells and chitosan. Such characteristic could be attributed to the electrostatic attractive force
between the positive charges of the protonated amine groups along chitosan chains and the
negative charges of the phospholipid structure of the cell membrane. We propose that this bioadhesive property of chitosan could potentially improve neuron adhesion and neurite outgrowth,
making chitosan a promising biomaterial candidate in the field of neural engineering.
In Chapter II, we simply blended chitosan with a well-studied hydrogel system (agarose).
This hydrogel system showed good neuron-adhesive property. The concentration of chitosan also
had great influence on neurite extension. A “steric hindrance” hypothesis was proposed to
explain the observations in biological study. It implies that a proper adjustment of the blend
composition could directly impact the morphological development of neurons, and could be used
as a simple yet versatile approach to obtain desirable neuronal structures. The simplicity of
preparing this hydrogel system also allows for future applications of agarose-based hydrogels for
neural tissue repair.
In Chapter III, we developed a brand new graphene-chitosan nanocomposite system as a
potential substrate material for implantable neural electrodes. The free standing film prepared
by air evaporation showed good flexibility. The electrical conductivity of graphene was
maintained after the incorporation of chitosan. Biological studies showed good biocompatibility
of graphene and good cell-substrate interaction between neuron and G-C nanocomposites with
proper compositions. The promising results indicated the potential impact of G-C
nanocomposites on the clinical translation of neural interface technology by improving the long15

lasting performance of the implant through fundamental changes of the substrate material used
for implant fabrication.
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CHAPTER II
CHITOSAN-AGAROSE HYDROGELS FOR BRAIN REPAIR
An article presenting part of the results in this chapter has been published on
Biomacromolecules [Zheng Cao, Ryan Gilbert, Wei He. Simple agarose-chitosan gel composite
system for enhanced neuronal growth in three dimensions. Biomacromolecules 2009, 10 (10),
2954-2959]. Published data include: Fig. 2.3, Fig. 2.4, Fig. 2.5 (a, d and g), Fig. 2.6, Fig. 2.7,
Fig. 2.8, Fig. 2.9, Fig. 2.10, and Fig. 2.11. Section 2.3.2, 2.3.3 and 2.4 are directly cited from the
article with a few modifications. Section 2.1, 2.2 and 2.3.1 are newly written.
The first author (Zheng Cao) finished all of the experiments in this study. The third and
corresponding author (Dr. Wei He) is advisor of Zheng Cao and financially supported this work.
The second author (Dr. Ryan Gilbert) is a collaborator of Dr. Wei He, and gave professional
advice on this work.

2.1 Introduction
Chitosan itself can be fabricated into a three-dimensional (3D) hydrogel using salts or
other agents. However, our preliminary data indicate that chitosan hydrogel is non-permissive for
neural growth. A well studied hydrogel system, agarose, was selected as the hydrogel matrix for
this study. Agarose, a biocompatible polysaccharide, is widely investigated as a 3D scaffold for
neural engineering. In the form of a hydrogel, agarose has porous structure59 and provides a
friendly environment for cellular spreading and proliferation.60, 61 The main issue for agarose to
be used as a neural scaffold is its incapability to support cell attachment.62 Previous study has
shown chemical functionalization of agarose with neuro-adhesive components could improve E9
chick DRG neurite extension, but the complex chemical process is costly and time-consuming.60
Here, we chose to blend chitosan into agarose hydrogel to simplify the preparation process and
investigate its potential application for brain repair. The influences of chitosan on neuron
adhesion and neurite extension were also studied.
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2.2 Preliminary Study for Chitosan Selection
2.2.1 Rationales
As mentioned earlier, the values of DDA and MW could affect the physical properties of
chitosan. Currently, there are a variety of chitosan products available in the market, with
different origins and chemical structures. Because it is not practical to perform the work using all
types of chitosan, we need to indentify one most suited for the intended applications first. To
avoid the influences from origin and processing, a series of chitosan from one vendor will be
compared. Because characterization and modification of chitosan are not parts of this study, only
products with known values of DDA and MW were considered. After a brief investigation, a
series of chitosan (Sigma) with similar values of DDA (75% - 85%) but different MW (LMW:
50,000-190,000 g/mol; MMW: 190,000-310,000 g/mol; HMW: 310,000-375,000 g/mol) were
selected for preliminary study. Because chitosan with the same MW but different DDA are not
readily available, the effect of DDA on neuron growth will not be considered here.
The three types of chitosan were generously provided by Dr. Kevin M. Kit (Department
of Materials Science & Engineering, UTK) and Dr. Svetlana Zivanovic (Department of Food
Science and Technology, UTK). Three chitosan-agarose (C-A) hydrogels with consistent
concentration (both C and A: 1 wt%) were prepared. Plain agarose hydrogels (1 wt%) served as a
control. Primary chick cortical neurons were cultured on the samples for 3 days and
characterized using confocal microscopy. Hydrogel sample supporting the most neuron adhesion
(i.e., highest cell density) and neurite outgrowth (i.e., best neural network) is considered as the
premium substrate, and chitosan used for that sample will be employed for the rest of the study.
Detailed procedures related to sample preparation and in vitro study are described in the
following sections.
2.2.2 Results & Conclusion
A drastic increase of cell number was observed on all C-A hydrogels (Fig. 2.1 (a) – (c))
compared with plain agarose hydrogel (Fig. 2.1 (d)), which confirms our hypothesis that
chitosan could improve neuron adhesion. In addition, a better neural network was developed on
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Figure 2.1 Neuron growth on C-A prepared with different types of chitosan: (a) LMW, (b) MMW, (c)
HMW, and (d) plain agarose. Scale bar = 300 μm.
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C-A hydrogel made from LMW chitosan (Fig. 2.1 (a)). Therefore, LMW chitosan was selected
for the rest of the study.

2.3 C-A Hydrogels for Brain Repair
2.3.1 Rationales
This section briefly introduces the rationales behind the experimental design and special
techniques used in this chapter. Please see section 2.3.2 Experiments for detailed experiments.
2.3.1.1 Sample preparation
The concentration of chitosan is the only variable in sample preparation. As mentioned
earlier, solutions with chitosan concentration above 3 wt% are not feasible due to the large
increase in viscosity of the solution and the limited solubility of chitosan.2 Therefore, the
concentration of chitosan was kept below 3 wt%. Acetic acid aqueous solution was used to
dissolve chitosan. SeaPrep® agarose was selected according to a previous study60, and was
kindly donated by Lonza Rockland. A consistent agarose concentration (1 wt%) was maintained
for all the samples as this concentration of SeaPrep® agarose gel supported the best neurite
outgrowth from chick DRG. Moderate heating (~60 °C) is required to dissolve this SeaPrep®
agarose in water, and relatively low temperature (10 – 17 °C) is necessary for the solution to
form a gel. Therefore, after plating final solutions in glass-bottom petri dishes, samples were
kept in a refrigerator for gelation. Generally, all of the hydrogel compositions can gel within 20
min at 4 °C. A rinse with basic phosphate buffered saline (PBS) was applied for all C-A
hydrogels to neutralize the acid. For biological study, samples also need to be sterilized. A 20
min UV exposure was utilized for sterilization as opposed to commonly used autoclave
approach, considering the hydrating nature of the gel.
2.3.1.2 Sample characterization
Because studies have shown the mechanical properties of a substrate have great influence
on neuron adhesion and growth,20 the stiffness of the hydrogels was evaluated by a rheometer
according to a previous study.63 The purpose of this measurement is to determine if the
incorporation of chitosan influences the mechanical properties of agarose gel, thereby affecting
the neuron adhesion and growth on C-A hydrogels.
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C-A hydrogels were as clear as plain agarose after gelation, but they turned into opaque
after the basic rinse. Therefore, the structure of the hydrogels was characterized by light
microscopy and scanning electron microscopy (SEM). The internal structure of the hydrogels
was observed under a light microscope with oil lens for high magnification imaging. The surface
structure of the samples was characterized by SEM.
2.3.1.3 Primary cortical neuron culture
Instead of using neuron cell lines, primary chick cortical neuron was used for the in vitro
study to better represent the neuronal responses in real brain tissue. According to our previous
experience, primary cortical neurons are especially “picky” and can only attach on specially
treated substrates (e.g., laminin coated petri dish). Failure in adhesion will eventually lead to cell
death. Cortical neurons were harvested from the forebrain of a 9-day old chick embryo. To
disaggregate the forebrain tissue, a combination of chemical and mechanical dissociation
methods was utilized to prepare a suspension of single cells. Cell purification can be achieved by
incubating the cell suspension on a collagen coating. This process has been reported to provide
culture with 97% of neuron composition.64 It is worth noting that primary cortical neurons do not
proliferate, which is different from commonly used neuron cell lines. Therefore, the number of
neurons on substrates can only decrease due to cell death, but will not increase during culture.
2.3.1.4 Fluorescent microscopy
Because the neutralized C-A hydrogels were opaque, the cell cultures on these samples
could not be directly observed under a inverted light microscope. Accordingly, a live staining
technique (Live/Dead Viability/Cytotoxicity Kit for mammalian cells, Invitrogen) was applied to
enable cell emitting green fluorescence under a fluorescent microscope. The principle behind this
method is that live cells can absorb the nonfluorescent staining agent (calcein AM) and
enzymatically convert it into fluorescent calcein, while dead cells are unable to achieve the
conversion. In this way, only cells survived during the culture will be detected under the
fluorescent microscope. To save time, images at certain magnifications were taken for all
cultures first and analyzed later.
Because agarose gel is a 3D permissive scaffold for cell growth, a laser scanning
confocal fluorescent microscope was used to collect signals throughout the hydrogel. Confocal
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microscopy offers several advantages over a conventional optical microscopy, including the
ability to control depth of field, elimination or reduction of background information away from
the focal plane, and the capability to collect serial optical sections from thick specimens.65 Fig.
2.2 shows the principle of this technique. Using the software provided by the vendor, one
composite image showing all the information from the serial sections is achievable. The signal
can also be presented in different colors to show the 3D profile of the culture.
2.3.1.5 Assessment of neuron responses to substrates
There are a number of ways for assessing cellular responses to substrates. Cell viability is
the most commonly used one. By counting cell number on the substrate after a certain period of
culture and comparing with a positive or negative control, the biocompatibility of the substrate
can be evaluated. Plain agarose hydrogel was used as a control for this study because we would
like to see if the incorporation of chitosan could improve the neuron-adhesive property of
agarose hydrogel. To obtain quantitative results, the cell number within a defined area of a
substrate is counted and used to calculate the cell density (cells/cm2).
How well can neurons differentiate on/within a substrate is another important criterion
for neuron related study. For example, as shown in Fig. 1.3, the ultimate goal for neural tissue
engineering is to build a good network among neuronal cells and realize their normal functions
(signal transportation). The methods for assessing neurite outgrowth are well summarized by
Radio and Mundy,66 including semi-quantitative, quantitative, and biochemical assessments.
Each of these categories has their advantages and disadvantages (Table 2.1). For semiquantitative methods, the exact length of neurite will not be measured. It is only used for
classifying cells into different groups, such as cells with neurites and cells without neurites.
Therefore, the assessment can be simple and rapid, and no special technique or software is
required. The results might be subjective, however, with a risk of scoring bias. Quantitative
assessment, on the other hand, can be quite time-consuming and work-demanding if analysis is
done by hands. Software could be employed for analysis, but it can be fairly expensive.
Accuracy is the advantage of this kind of method. Neurite outgrowth can also be quantified using
a variety of biochemical markers, based on the assumption that biomarkers correlate with both
differentiation and increases in neurite length. Procedures, such as enzyme-linked
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Figure 2.2 Principle of confocal microscopy.65
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Table 2.1 Methods for assessment for neurite growth.
Method

Advantages

Disadvantages

Examples

Semiquantitative

Rapid
Simple
Inexpensive

Can be subjective

Number of cell exhibiting neurites
Percentage of cells exhibiting neurites
Number of neurites per cell

Quantitative

Accurate

Time-consuming
Greater amount of work
Expensive

Length of the longest neurite
Total neurite length
Average neurite length

Rapid

Costly
There may not be a direct
relationship
between
the
biomarker expression and neurite
length.

ELISA
Immunoblotting
Proteomic techniques

Biochemical
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immunosorbent assay (ELISA), immunoblotting, and proteomic techniques, are useful in high
throughput screening. The measurement can be rapid, but the biochemical reagents used for
marking neurites are often expensive. There is also a concern about the accuracy between the
biomarker expression and the actual neurite length. Considering the availability of techniques
and the cost of the assessments, a semi-quantitative method was selected for this study. Instead
of just calculating the percentage of cells exhibiting neurites, we categorize cells into four groups
according to the length of their longest neurite. Briefly, four different ranges of neurite length
were predetermined, including 0 – 25 μm, 25 – 50 μm, 50 – 150 μm and >150 μm. Each cell on
the substrate was classified into one of the four groups according to the length of its longest
neurite. For example, if a neuron has four neurites and the longest one is 100 μm in length, this
cell will be put into the 50 – 150 μm group. After all cells on one substrate were grouped, the
percentage of cells exhibiting different length of neurites was calculated and compared.
2.3.1.6 Statistical analysis
Statistical analysis is a very important technique in biological studies. Considering the
randomness and unpredictable variability during sample preparation and data collection,
repetition must be conducted before achieving any solid conclusion. In this study, all cultures
were repeated three times, meaning that each sample was subjected to cultures on three separate
days. A statistical software (SAS) was used for the data analysis.
2.3.2 Experiments
2.3.2.1 Preparation of C-A
A series of C-A hydrogels with chitosan content varying between 0 and 3 wt% were
prepared following a simple procedure. Hydrogels with higher chitosan concentration beyond 3
wt% are not feasible and reliable for cell culture work due to the large increase in the viscosity of
the solution and the limited solubility of chitosan.2 Briefly, chitosan (LMW, Sigma) was first
dissolved in a 2.5 wt% acetic acid solution. SeaPrep® agarose (Lonza) (1 wt%) was then added
to the chitosan solution and dissolved by heating the mixture in a 60 °C water bath. To prepare
hydrogels for cell culture, 100 μl of the final solution was plated in a glass bottom petri dish
(well: 1.4 cm in diameter, MatTek), and stored in a 4 °C refrigerator overnight to ensure
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complete gelation. Neutralization was achieved by extensive rinsing of the hydrogel with basic
phosphate buffered saline (PBS) solution (pH = 8.5). Plain agarose hydrogels (1 wt%) were
prepared as a control following a similar procedure, without the addition of acetic acid and
neutralization. All hydrogels were sterilized in sterile PBS solution (pH = 7.4) by UV light
exposure for 20 min before the cell culture.
2.3.2.2 Rheological study of C-A
The mechanical stiffness of the hydrogel was determined by dynamic mechanical
spectrometer (TA Instruments AR2000 rheometer, USA) at 37 °C with parallel plates. The
complex modulus, G*, was determined at a constant strain (0.1%) for a frequency range of 0.1 to
100 rad/s. The stable plateau modulus, at frequencies between 0.1 and 10 rad/s, was used to
approximate the equilibrium modulus, G, according to a previous study.63
2.3.2.3 Morphological study of C-A
The morphological structure of the hydrogels before and after basic buffer rinsing was
directly imaged using a light microscope (Nikon Eclipse Ti, Japan) at a magnification of 100X.
Then the samples were freeze-dried, sputter-coated with gold and imaged using a SEM (LEO
1525, Germany).
2.3.2.4 Primary cortical neuron culture on C-A
Cortical neurons were obtained from 9-day old chicken embryos. Forebrains of the
embryo were dissected, minced into small pieces, and enzymatically dissociated with 0.25%
trypsin in PBS for 20 min at 37 °C, followed by inactivation with medium containing 10% fetal
bovine serum (FBS, Invitrogen). A cell pellet was obtained after a brief centrifugation, and
mechanical trituration using a fire-polished Pasteur pipette was applied to further dissociate the
cells. Cells were then preplated on a collagen-coated petri dish and incubated for 1 h at 37 °C in
a 5% CO2 atmosphere. Purified neuronal cells were collected and re-suspended for cell culture.
After counting, cells were seeded on sterile hydrogels with a density of 2×104 cells/cm2,
and cultured in Dulbecco’s modified Eagle’s medium supplemented with 10% FBS, 1%
penicillin/streptomycin and 1% L-glutamine at 37 °C in a 5% CO2 atmosphere for a
predetermined time as specified in the following section. Nerve growth factor (NGF) is not
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required to induce chick cortical neuron differentiation and neurite outgrowth.67 Therefore, NGF
was not used in the cortical cell culture. Each of the hydrogel compositions was tested three
times, meaning that each hydrogel was subjected to cultures on three separate days.
2.3.2.5 Neuron adhesion on C-A
At the end of 3-day culture, cells were live stained with 0.05 v/v Calcein AM (Invitrogen)
solution in PBS, and incubated at 37 °C in a 5% CO2 atmosphere for 30 min. Samples were
rinsed twice with PBS before and after fluorescence staining. Fluorescent images were taken
using a 10X objective lens on a confocal microscope (Leica SP2, Germany). Neuron adhesion on
the hydrogels was assessed by counting cell density (cells/cm2).
2.3.2.6 Neurite extension on C-A
For neurite extension quantification, a cellular process being equal to or greater than 25
μm is defined as a neurite. The length of the longest neurite per neuron was used to analyze the
percentage of neurons with different neurite outgrowth (25 – 50 μm, 50 – 150 μm, and >150 μm)
on three representative areas for each 3-day cell culture sample.
2.3.2.7 Neuron morphology on C-A
Neuron morphology was analyzed for 5-day cell cultures following the same live staining
procedure as describe above. The samples were imaged on the confocal microscope. The
network of neurons was imaged at with a 10X lens, and detailed morphological images of
representative cells were captured with a higher power lens (63X). In order to correlate the
observed neuron morphology with the structure of various C-A hydrogels, surface features of the
gels obtained from the light microscopy images were simulated by distributing different
percentages of random dots (1 unit, representing the chitosan component) in a blank area (100 x
100 units, representing the agarose matrix) using a Matlab program.
2.3.2.8 Statistics
Data were analyzed using analysis of variance (ANOVA, SAS 2008), and least squares
means were compared by Tukey’s test. Differences were accepted at a significant difference
value of p < 0.05. All data were reported as the mean ± standard deviation.
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2.3.3 Results & Discussion
2.3.3.1 Rheological study of C-A
Recent work has demonstrated that the stiffness of substrates influenced the adhesion and
morphology of tissue cells,68, 69 and softer substrates were more favorable at facilitating neuronal
differentiation than harder ones.20 As one of the key features of agarose gel for nerve repair lies
in its close mechanical matching with the neural tissue, it is important that such feature is not
compromised with the blend of chitosan. Although the introduction of chitosan slightly
decreased the value of G (plain agarose hydrogel: ~75 Pa; C-A hydrogels: 20 ~ 70 Pa), the
stiffness of the C-A hydrogels were still on the order of 100 Pa (Fig. 2.3), which is very close to
the stiffness of the brain tissue.70 Therefore, from the mechanical property perspective, all of the
C-A hydrogels are comparable to plain agarose and should have similar influence on neuronal
growth.
The cause of slight reduction in the stiffness of the 0.33% C-A hydrogel is unclear. Clark
et al.71 have reported similar observation in the agar/gelatin co-gels, where the shear modulus of
the gel first falls as gelatin is added and then increases again with more addition of gelatin. The
authors attributed the minima to the interference effect, i.e., the concentrating action of the
gelatin aggregation is insufficient to increase the gel strength of the initially formed agar phase to
match the value of a pure agar gel until the gelatin concentration reaches beyond the phase
inversion point. We speculate the chitosan molecule has similar interference effect on agarose in
our hydrogel system, but the exact mechanism is beyond the scope of this study.
2.3.3.2 Morphological study of C-A
All non-rinsed C-A hydrogels were as clear as the plain agarose gel (not shown), but they
displayed an opaque appearance after neutralization (Fig. 2.4 (a)). The extent of the opacity
directly corresponds to increasing concentrations of chitosan. Light microscope images show
aggregates within the agarose matrix (Fig. 2.4 (b)). A correlation between the density of
aggregates and concentration of chitosan was observed too. The morphology of samples was also
investigated using SEM. C-A hydrogel with 3.0 wt% of chitosan collapsed during sample
preparation, thus images are not available for this composition. As shown in Fig. 2.5, plain
agarose hydrogel and non-rinsed C-A hydrogels display opened porous structure, while rinsed C28

Figure 2.3 Equilibrium modulus G versus chitosan concentration: The stiffness of brain, skeletal muscle,
and cartilage are presented for comparison.70
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Figure 2.4 Photograph and light microscope images of hydrogels: (a) Photographs demonstrating the
opaque appearance of C-A hydrogels compared with plain agarose gel and (b) light microscope images
(100X) showing the structure of hydrogels. Concentration of chitosan from top to bottom: 0% (plain
agarose), 0.33%, 1.0%, 2.0%, and 3.0%. Scale bar = 10 μm.
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100X

4000X

before rinse
Figure 2.5 SEM microscope images showing the structure of hydrogels: (a) plain agarose; C-A hydrogels
before and after neutralization: (b & e) 0.33%, (c & f) 1.0% and (d & g) 2.0%. 100X: scale bar = 200 μm;
4000X: scale bar = 5 μm.
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100X

4000X

after rinse
Figure 2.5 continued.
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A hydrogels form partially or fully closed structure. Higher magnification images (4000X) reveal
a relatively smooth structure for non-rinsed C-A hydrogels and grainy structure for rinsed
samples.
These observations can be attributed to the phase separation of chitosan in the neutralized
hydrogels (Fig. 2.6). Briefly, the chitosan used in this study is only soluble in acidic solutions
(pH < 6.5) due to the electrostatic effect among the protonated amine groups along the polymer
chains.2 Under this condition, the C-A hydrogel forms a homogeneous phase with extended
chitosan chains within the agarose matrix and displays a clear appearance. The electrostatic
effect, however, is diminished in neutral environments because most of the amine groups are
deprotonated when pH values approach 7.4.72 Therefore, the extended chitosan chains contract
after neutralization, and aggregates of chitosan precipitated within the agarose matrix, resulting
in the phase separation.3 We have observed with a light microscope a uniform distribution of the
chitosan aggregates throughout the entire depth of the gel, indicating a well-dispersed precipitate.
It is also worth noting that the size of the chitosan aggregates (average estimated diameter of 1
μm from SEM images) did not change much as the concentration of chitosan increased. The
apparent increase in opacity and the number of aggregates could be accounted for by the higher
concentration of chitosan.
2.3.3.3 Neuron adhesion on C-A
There was a significant difference in the number of live cells between hydrogels with and
without chitosan. All of the C-A hydrogels showed better support of neuron adhesion than the
plain agarose hydrogel (Fig. 2.7). As mentioned earlier, this difference is most likely due to the
ability of chitosan chains to interact with the cell membrane by electrostatic effect. Similar
results have also been reported for other types of cells, indicating a nonspecific interaction. It is
quite difficult to measure the surface potential of the hydrogels due to their low stiffness.
However, previous studies have already shown that even though most of the amine groups are
deprotonated in a neutral environment, there are still positive charges on the surface of
neutralized chitosan films49 and microspheres13.
Since chitosan can enhance the adhesion of neurons, one would expect a simple linear
relationship between the cell density and the chitosan concentration in the hydrogel. However,
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Figure 2.6 Schematic of phase separation of C-A hydrogel as a result of neutralization. Corresponding
chemical structure change of chitosan due to the pH change of the solvent is also given.
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Figure 2.7 Cell density versus chitosan concentration in C-A hydrogels. Error bar = standard deviation (n
= 3, *p < 0.05).
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this is far from the case. There was no significant difference in the cell density on the C-A
hydrogels within the concentration range of chitosan in this study, except the 3.0% C-A
composition (Fig. 2.7). Considering the size of the cell body (~15 μm) and chitosan aggregates
(~1 μm), it is reasonable to conclude that a single cell can interact with several chitosan
aggregates at the same time, and as long as sufficient chitosan is added, the change of chitosan
concentration would not influence the total number of cells attached on the substrates. This
observation is similar to studies demonstrating a surface cell-adhesive RGD ligand density
threshold, where increases in the RGD density did not significantly affect the number of cells
attached, suggesting a saturation of receptor-ligand bonds at higher ligand density.73 The number
of neurons attached on the 3.0% C-A gel is statistically lower than the rest of C-A compositions.
It could be due to the fact that the gel supported relatively poorer neurite development (as
discussed next) and therefore, a portion of the loosely adhered neurons died during culture or lost
during the staining process.
2.3.3.4 Neurite extension on C-A
For a substrate to be effective as a scaffold for neural tissue engineering, it should not
only support neuron adhesion, but also support neurite extension. Neurites are very important
projections of a neuron, as they will lead to the eventual formation of functional neural network
and enable synaptic transmission. It is therefore essential to examine how the C-A hydrogels
affect neurite outgrowth. Significant differences were observed for the ability of neurons to
develop neurites on different C-A hydrogels (Fig. 2.8). The percentages of cells that could
develop neurites longer than 50 μm (50-150 μm & >150 μm) after a 3-day culture on 3.0% C-A
gels were much lower than the others, and 2.0% formulation also lacked the ability to support
very long neurites (>150 μm). Such inhibition effect from substrates fabricated to facilitate
neurite extension has been observed in an earlier study on polylysine-functionalized chitosan
hydrogels.6 Crompton et al. found that immobilized poly-D-lysine (PDL) improved cell survival
up to an optimum concentration of 0.1%, and further increases of PDL resulted in a decrease in
cell number and neurite outgrowth. The authors attributed this result to the strong interaction of
cells with PDL in their 3D gel. We are proposing an alternative hypothesis to explain the
phenomenon observed in the present study. Our hypothesis is based on our observations from
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Figure 2.8 Percentages of neurons with different lengths of neurite versus chitosan concentration.
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neuron differentiation and morphology study, which will be further discussed in the following
section.
2.3.3.5 Neuron morphology on C-A
Neurons on all C-A hydrogels exhibited a 3D profile, as shown from the confocal images
where the cell body of the neuron situated at the surface of the gel and the neurites were seen
extending into the gel towards the bottom (Fig. 2.9 & Fig. 2.10). It indicated that the neuritepermissive property of the agarose scaffold was preserved despite the addition of chitosan.
However, cells on C-A hydrogels with lower chitosan concentration (0.33%, Fig. 2.10 (a))
tended to extend axons, typically the longest neurites, as a straight line without obvious
branching. Their counterparts on denser gels (1.0%-3.0%) favored tortuous axon morphology
with extensive branches (Fig. 2.10 (b) – (d)). This trend can also be seen on the confocal images
showing the overall feature of the network, although the fine structure of the neurites was not
visible under such low magnification (Fig. 2.9). Data for 0.66% and 1.5% C-A hydrogels were
not shown as the neurons on these two compositions exhibited similar properties as the 1.0%
formulation.
Why do neurons behave so differently on the simple blends of chitosan and agarose? In
order to answer this question, neuron differentiation was “simulated”, by hand, in twodimensional (2D) mimic structures of different C-A hydrogels (Fig. 2.11). The basis for this
simulation is the observation that chitosan aggregates in these C-A hydrogels are relatively
uniform in size (~1 μm) and randomly distributed (Fig. 2.4 (b)). Briefly, different percentages of
random dots (1 unit) in a blank area (100×100 units), corresponding to different chitosan
concentrations, were generated using Matlab. Neurites can only pass through the white area,
which represents the permissive agarose matrix. However, attaching a black dot (chitosan
aggregate) at each step is necessary for neurite extension. The distance between two steps must
be shorter than 6 units (6 μm), which is the reported critical bridge distance for the growth cone
at the end of an axon to migrate.74 Branching is preferable when the neurite has to make a sharp
turn. Although the “simulation” work was done in a 2D manner, the results shared quite similar
profiles with the neurons from the real confocal microscopy images (Fig. 2.10), reflecting the
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Figure 2.9 Confocal images of the neuron network on C-A. The highest depth neurites could reach is 160
μm below the surface according to our observations. Scale bar = 300 μm.
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Figure 2.10 Representative images showing neuron morphology on C-A. Color band indicates the depth
of the neurite location. Scale bar = 50 μm.
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Figure 2.11 ”Simulation” of neurite differentiations: simulated by hand on substrates mimicking the
hydrogels using random dots generated by Matlab.
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two-fold functions of chitosan aggregates during neuron differentiation: “adhesion sites” and
“steric hindrances”.
On the one hand, the positive charges on the chitosan aggregates support neurite
attachment during differentiation. According to the study by Clark et al.,74 the distance between
two attachment sites needs to be less than 6 μm to guarantee a successful forward procession for
growth cones. Because even the hydrogel with the lowest concentration of chitosan (0.33%) is
able to support neurons to develop fairly long neurites, it is reasonable to conclude that all of the
concentrations of chitosan are sufficient for satisfying the minimum gap distance for the growth
cone to move forward. Light microscopy images also show such a network with a comparable
inter-aggregate distance (Fig. 2.4 (b)).
On the other hand, the chitosan aggregates are formed by highly contracted polymer
chains, so it is not easy for neurites to penetrate these dense areas. When growth cones meet such
a “roadblock”, it is more favorable for them to make a turn and/or branch out to continue their
pathfinding. The more concentrated the C-A hydrogel, the higher possibility for the growth cone
to encounter a hindrance and make turns and branches. These side branches of neurites, also
known as collaterals, are quite favorable because they can form points of contact with
appropriate target neurons and provide more chances for signal transmission among neural cells.
However, the continuing increase of the chitosan concentration could have its drawbacks,
causing the chitosan aggregates to block neuronal outgrowth. We thus hypothesize that it is this
steric hindrance effect that caused the 3.0% C-A hydrogel to perform poorly for neurite
extension even though it should have the most attachment sites for neurons.
The two functions of chitosan play very important roles in enhancing neuron attachment
and guiding neurons to develop multi-branching neurites in a 3D manner, resulting in the
formation of a more extensive network and better communication among neural cells (Fig. 2.9).
The C-A hydrogel, taking advantage of the permissive structure of agarose hydrogels and the
two-fold properties of chitosan, can be a promising tissue scaffold for brain injury repair. Based
on our study, the optimum concentration of chitosan in the agarose gel is 0.66-1.5 wt%, which
supports more cells with longer neurites and better neural network compared with the other
compositions (Fig. 2.8 & Fig. 2.9).
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Although a few studies have previously reported that high substrate density can inhibit
nerve growth,75, 76 our work is the first one to demonstrate such an inhibition effect by correlating
the morphology of single cells and a 3D structured tissue scaffold. This hypothesis not only
explains our observations in the cell culture study, but also helps us better understand the
mechanism by which a neurite extends or branches.

2.4 Conclusions & Significance
A simply prepared C-A hydrogel system was developed for TBI repair. The stiffness of
the C-A hydrogels was very similar to the brain tissue, providing a mechanically compatible
environment for neuron growth. The agarose matrix presented a permissive structure for neuron
growth, and its incapacity for neuron adhesion was complemented by the addition of chitosan.
More importantly, a novel hypothesis on the “steric hindrance” effect of chitosan on neurite
outgrowth was proposed based on our observations. It implies that a proper adjustment of the
chitosan concentration could directly impact the morphological development of neurons, and
could be used as a simple yet versatile approach to obtain desirable neuronal structures.

This

hydrogel system and its multi-functionality allow for applications of simply prepared agarosebased hydrogels for neural tissue repair.
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CHAPTER III
GRAPHENE-CHITOSAN NANOCOMPOSITES FOR
NEUROPROSTHETICS
A manuscript presenting part of the data in this chapter has been submitted to Nano
Letters for review in March of 2010 [Zheng Cao, Yongchao Si, Craig Cavanaugh, Wei He.
Graphene-chitosan nanocomposite for neural interface applications]. Submitted data include:
Fig. 3.2, Fig. 3.3, Fig. 3.4 (a, e and f), Fig. 3.5, Fig. 3.6, Fig. 3.7, and Fig. 3.8 (a, c, e and f).
Section 3.1, 3.2.3 and 3.3 are mostly cited from the submitted manuscript with a few
modifications. Section 3.2.1 and 3.2.2 are newly written.
The first author (Zheng Cao) finished all of the experiments in this study. The fourth and
corresponding author (Dr. Wei He) is advisor of Zheng Cao and financially supported this work.
The second author (Dr. Yongchao Si) and (Dr. Craig Cavanaugh) are collaborators of Dr. Wei
He, and provided the graphene solution and professional advice for this work.

3.1 Introduction
Successful interfacing with neural tissue holds enormous potential for both fundamental
neuroscience research and clinical treatment of neurological diseases or injury.77-82 A key
component of this application is the implantation of the device in neural tissue to exchange
information with local population of neurons. Currently, these implantable devices suffer from
large variability and limited longevity in performance, which is one of the major bottlenecks for
neural interface technology.78, 79, 82 To address this challenge, the neural interface community is
exploring novel implantable materials.48 In this study, we rationalize that graphene-based
materials could potentially be used for implantable neural devices.
Graphene (G), a 2-D monolayer of carbon atoms covalently-bonded in a hexagonal array,
is being intensively studied since the discovery of processes enabling the exfoliation of G into its
free-standing form.83 Its excellent properties, including high values of electrical conductivity,84
thermal conductivity,85 and specific area,86 make it a promising candidate in a variety of
applications, such as energy storage materials,86 polymer composites,87,
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liquid crystal

devices,89 etc. Unlike carbon nanotubes (CNTs), its sibling in the family of carbon materials,
very limited study has been reported on the applications of graphene in biomedical fields.90, 91
Use of CNTs for biomedical applications, particularly those involving placement inside the body,
faces a toxicity issue. Studies have reported that CNTs may insert themselves between the lipid
bilayer of cell membrane, leading to membrane disruption and cell death.92-95 Toxicity issues
also arise from the intrinsic impurities from the catalysts used for CNT production.96-98 Although
graphene sheets are ultra-thin (~1 nm), a relatively large lateral size (several micrometers) on the
2D plane is achievable.99 This could result in less size-induced toxicity than CNTs. Furthermore,
graphene production is less plagued with impurity issues,100 which benefits biomedical
applications.
Currently, four methods have been used to prepare graphene: chemical vapor deposition
(CVD) and epitaxial growth, micromechanical exfoliation of graphite, epitaxial growth on
electrically insulating surfaces, and creation of colloidal suspensions.100 Among these methods,
production of graphene from colloidal suspensions is the most scalable and versatile approach.
This allows for potential mass production and a variety of chemical functionalizations. Typically,
graphene cannot be easily dispersed in water, which is the most preferred solvent for biomedical
applications. This challenge has been addressed by the development of water soluble graphene
with the introduction of sulfonate groups, which can be readily dispersed in water at reasonable
concentrations (2 mg/mL) with its electrical conductivity preserved.99 It provides an opportunity
to explore the biomedical potentials of graphene.
Graphene is non-biodegradable, thus suitable for long-term in vivo applications. It is also
electrically conductive, thus able to provide a communication platform with neurons. To improve
its interaction with neurons, we complemented graphene with chitosan (C), to form a
nanocomposite. Results from Chapter II have shown that inclusion of chitosan can significantly
improve neuron adhesion to substrates. In this chapter, graphene-chitosan (G-C) nanocomposites
were prepared and characterized for properties pertinent to neural interface applications.
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3.2 G-C Nanocomposites for Neuroprosthetics
3.2.1 Rationales
This section briefly introduces the rationales behind the experimental design and special
techniques used in this chapter. Please see section 3.2.2 Experiments for detailed experiments.
3.2.1.1 Sample preparation
The concentration of chitosan is the only variable in sample preparation. A stock chitosan
solution was prepared first, and added into graphene later. A graphene stock solution (0.5 mg/mL
in DI water) was directly provided by our collaborator Dr. Craig Cavanaugh and Dr. Yongchao
Si from University of North Carolina at Chapel Hill. A consistent graphene concentration (0.4
mg/mL) was maintained for all the G-C solutions. Although both coatings and free standing
films can be prepared by air evaporation of the G-C solution, G-C coatings on glass will be used
for most of the study due to its ease of preparation and handling. These experiments include:
electrical property, surface morphology and topography, neuron adhesion, and neuron
morphology.
The flexibility of G-C was examined by rolling the free standing film up. An insertion
test was done to show its feasibility for surgical implantation.
3.2.1.2 Sample characterization
The remarkable electrical conductivity of graphene is one of the main rationales behind
this study. Because chitosan is non-conductive, the electrical property of G-C needs to be
confirmed first. The electrical resistance of G-C was measured using a multimeter.
The surface topographical features can have great influence on cell adhesion and
growth.101 Therefore, two methods (SEM and AFM) were selected in this chapter to characterize
the surface structure of G-C samples. Typically SEM can only detect information at the microscale due to its limited magnification, but a large area could be scanned at one time. AFM, on the
other hand, could provide nano-scale information but with a relatively small scanning area.
Results from these two methods could give us a comprehensive idea about the structural
properties of the sample surface. The roughness of the surface can also be calculated using the
software provided by the AFM vendor.
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3.2.1.3 Biocompatibility of G
Good biocompatibility is one of the most critical features that a biomaterial should
possess. As mentioned earlier, graphene could have lower cytotoxicity due to its large lateral size
on the 2D plane. Typically there are two ways to evaluate the biocompatibility of a film
substrate. One way is directly seeding cells on the fabricated substrate and assessing the cell
viability after culture. Another way is culturing cells on a good substrate using growth medium
supplemented with the raw material used for the substrate fabrication. The second method was
applied in this study because it can reflect the toxicity of single graphene sheets on cells.
To compare our results with a previous work studying the cytotoxicity of CNTs,98 we
employed a fibroblast cell line (NIH 3T3) in this study. A relatively high treatment concentration
(25 μg/mL) was selected for the culture. Besides, a neuron cell line (N2a) was also used for
cytotoxicity study, since this study is designed for neural engineering applications.
3.2.1.4 Neuron responses to substrates
Since this G-C nanocomposites system is newly developed, both cell line (N2a) and
primary cortical neurons were used for neuron adhesion study. Due to their different
characteristics, different culture times were employed. Because N2a can attach easily on many
substrates and proliferate quickly in serum-supplemented medium, a relative short culture period
(4-hour) was chosen for culture. On the contrary primary cortical neurons only attach on
specially treated substrate and don’t proliferate during culture, a longer culture period was used.
A poly-L-lysine (PLL) coating on glass was used as a positive control. All cell adhesion data
were normalized as percentages to PLL.
Like the C-A hydrogel study, neurite outgrowth was also evaluated for primary culture. A
different technique was used here for the following reasons. The highest magnification lens of
the confocal microscope used in this study is 63X, with which we cannot see much detail related
to the interaction between neurons and the substrate. Because the G-C coatings are dark in
appearance, a conventional inverted light microscope cannot be used for observation. SEM
imaging, due to its high magnification and easy imaging on sample surfaces, was used for neuron
morphology characterization in this study. Because the glass supported G-C coatings are dry and
rigid, SEM fixation is feasible. The reason that we did not use this method for the hydrogel study
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is because there is a concern about the dehydration process in the SEM fixation, which may
destroy the hydrogel structure and the interaction between the cells and substrate. Because cells
are not conductive, a gold sputter coating needs to be applied on the samples before imaging.
3.2.2 Experiments
3.2.2.1 Preparation of G-C
Chitosan was firstly dissolved in a 2.0 wt% acetic acid solution to a final concentration of
16 mg/mL. A series of G-C solutions (weight ratio: 1:0, 1:0.5, 1:1, 1:4 and 1:8) were prepared
with graphene suspension (0.5 mg/mL, Allotropica Technologies), DI water and the chitosan
stock solution. A consistent graphene concentration (0.4 mg/mL) was maintained for all
formulations. Table 3.1 shows the formulations for all samples prepared.
Stability of the G-C dispersions was examined by visual inspection after 24 h of sitting.
Supported G-C nanocomposite films were prepared by evaporation on glass. Briefly, 100 μl
dispersion of G-C was casted on substrates and allowed slow evaporation overnight at room
temperature. Thin free standing G-C films were prepared on poly(dimethyl siloxane) (PDMS) in
the same way, except larger volume of dispersions were used.
3.2.2.2 Electrical property of G-C
The resistance of both plain graphene (PG) and G-C composite films was measured using
a multimeter (Resistivity Meter SRM-232, Guardian Manufacturing Inc.) to determine if the
electrical characteristic of graphene is lost after the addition of chitosan, a non-conductive
polymer.
3.2.2.3 Surface morphology and topography of G-C
The surface and cross-sectional structure of the nanocomposite films was characterized
with SEM. Atomic force microscope (Agilent AFM 5500) measurement was performed in
contact mode for nano-scale characterization on the surface of uniform films. Both average and
root mean square roughness can be calculated using the customized software of the AFM.
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Table 3.1 Formulations for G-C Nanocomposites
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3.2.2.4 Cytotoxicity of G
Culture medium for NIH 3T3 is Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% Hyclone FetalClone III (Thermo Scientific), 1% penicillin/streptomycin
(P/S) and 1% L-glutamine. Medium for N2a culture DMEM supplemented with 10% fetal
bovine serum (FBS), 1% P/S, and 1% L-glutamine. Cells were seeded on 48-well plates (1×104
cells/cm2) and cultured in medium. After a 4-hour incubation at 37 °C in a humidified 5%
CO2/95% air atmosphere, half of the cultures was treated with graphene solution to a final
concentration of 25 μg/mL.98 The cells were cultured for another two days. Then the viability of
cells was characterized using WST-1 assay (Roche) following the recommended procedure by
the manufacturer. The absorbance was measured using an ELISA plate reader at 450 nm.
3.2.2.5 Neuron adhesion on G-C
As N2a can attach easily on many substrates and proliferate soon in serum-supplemented
medium, a relative short culture period (4-hour) was chosen for culture (seeding density: 4×104
cells/cm2). Primary cortical neurons were harvested from 9-day-old chicken following the
procedure described earlier (section 2.3.2.4 Primary cortical neuron culture on C-A). Because
primary cortical neurons do not proliferate, a 5-day culture was used for both cell adhesion and
morphology study (seeding density: 2×104 cells/cm2).
At the end of the cultures, cells were live stained with 0.05 v/v Calcein AM solution in
PBS and incubated at 37 °C for 20 min. Samples were rinsed twice with PBS before and after
fluorescence staining. Fluorescence images were taken using the confocal microscope. Neuron
adhesion on the substrates was assessed by counting cell number using Image J. The results were
expressed as percentage to the PLL positive control.
3.2.2.6 Neuron morphology on G-C
Primary cortical neuron was cultured for neuron morphology study. After the fluorescent
imaging, cultures were fixed and dehydrated. Briefly, cells were washed twice with 0.1 M
Millonig’s phosphate buffer (Electron Microscopy Sciences), followed by primary fixation with
3% glutaraldehyde (Electron Microscopy Sciences) in the same buffer for 1 hour at room
temperature. Then cells were rinsed with buffer for 3 times (10 min each). Secondary fixation
50

was performed for 30 min with 1% osmium tetroxide (Electron Microscopy Sciences). Cell
dehydration was carried out using ascending grades of ethanol (25%, 50%, 75%, 95%, 100%,
and 100%) for 10 min at each grade. Subsequently, samples were immersed in the mixtures of
ethanol and hexamethyldisilazane (HMDS) with a descending order of ratio (ethanol: HMDS =
2:1, 1:1, and 1:2), followed by 100% HMDS dehydration twice for 10 min each. Samples were
vacuum dried and kept in a desiccator to ensure a complete evaporation of HMDS. For imaging,
samples were mounted on aluminum stumps, coated with gold in a sputtering device, and
examined by SEM.
3.2.2.7 Statistics
The same technique as described in section 2.3.2.8 Statistics was used for statistical
analysis.
3.2.3 Results & Discussion
3.2.3.1 Preparation of G-C
A prerequisite for the preparation of a uniform film is an even dispersion of the source
solution. As shown in Fig. 3.1 (a), solutions of plain graphene (PG), G-C composites with
graphene to chitosan ratios of 1:4 (G1C4) and 1:8 (G1C8) were stable and well-dispersed after 1
day or longer, while G-C composite with graphene to chitosan ratio of 1:0.5 (G1C0.5) and 1:1
(G1C1) precipitated at the same time point. Obvious aggregates were observed right after the
mixing of graphene and chitosan solution for G1C1.It has been suggested that the repulsive
electrostatic force between the negatively charged graphene sheets (Fig. 3.2) accounts for the
stability of the PG dispersion.99 In this case, the introduction of positively charged chitosan
solution likely neutralized the negative charges on graphene, resulting in the collapse of the
graphene dispersion (G1C1). When less chitosan is added, the graphene is not totally neutralized,
resulting in a partially precipitated solution (G1C0.5) (Fig. 3.1 (b)). When additional chitosan is
added, the final solution becomes well-dispersed again (G1C4 and G1C8), most likely due to the
positive charge from the excess chitosan. The exact mechanism underlying the interactions
between graphene sheets and molecular chains of chitosan is yet to be elucidated, but we did
notice a darker appearance for G1C8 compared with other compositions, even though all samples
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Figure 3.1 Photograph of G-C dispersions: (a) at various ratios of graphene to chitosan; (b) partially
precipitated G1C0.5 solution after 1 day sitting; (c) & (d) the darker appearance of G1C8 compared with
G1C4.
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Figure 3.2 Chemical structure of chitosan and water soluble graphene.
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should have the same amount of graphene (Fig. 3.1 (c) & (d)). It would be informative to
uncover the microstructures of the components in the G-C solutions in future studies.
A free standing film was prepared by evaporating G1C4 solution on a PDMS block. The
films can be easily peeled off the PDMS and rolled up (Fig. 3.3 (a) - (c)), demonstrating good
flexibility. This is a desirable feature for implantable neural prosthesis.102,
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It was also

confirmed that the G-C films are mechanically strong enough for insertion, by testing with an
agarose gel mimicking brain tissue (Fig. 3.3 (d)).
3.2.3.2 Electrical property of G-C
The G-C films remained electrically conductive, with resistance lower than that of a
silicon wafer (Table 3.2). As expected, the G-C nanocomposites were less conductive than the
PG, and the more chitosan in the composite, the higher the resistance. The ability of graphene to
impart electrical properties to non-conducting polymer is consistent with previous reports of
electrically conductive polystyrene-graphene composite material.87 Though we demonstrated that
the G-C nanocomposites can be electroactive, the G : C ratio in the nanocomposite requires
further optimization in order to achieve an electrical property suitable for neural interfacing.
3.2.3.3 Surface morphology and topography of G-C
Surface properties play critical roles for biomaterials. Specifically, surface morphology
directly impacts cellular interactions with the biomaterial. Scanning electron microscope (SEM)
images show the surface morphology of the supported films and the cross-section structure of a
free-standing G1C8 film (Fig. 3.4). A drastic change in morphology can be seen between PG and
G-C composites. While PG forms a smooth surface at the micro-scale (Fig. 3.4 (a)), G-C
composites have a relatively rough surface (Fig. 3.4 (b) – (e)). Among G-C composites, the
surfaces of G1C4 and G1C8 possess uniform grainy structure (Fig. 3.4 (d) & (e)), while G1C0.5
and G1C1 display a surface feature between PG and G1C4 / G1C8 (Fig. 3.4 (b) & (c)).

The

cross-sectional image (Fig. 3.4 (f)) shows a continuous internal structure of the nanocomposite,
suggesting good percolation of graphene in the nanocomposite. This enables graphene to exert its
electrical functionality.
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Figure 3.3 Photograph of free standing G-C films: (a) – (c) A free standing G-C nanocomposite films
displays flexibility and ease of handling. (d) Insertion test of a free standing graphene-chitosan
nanocomposite film with an agarose gel mimicking the brain tissue.
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Table 3.2 Electrical resistance of plain graphene (PG), graphene-chitosan composites, and silicon wafer.
Data shown as mean ± standard deviation.
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Figure 3.4 SEM images showing the surface morphology of samples: (a) PG, (b) G1C0.5, (c) G1C1, (d)
G1C4, (e) G1C8, and (f) the cross-sectional structure of a G1C8 free standing film. The way to prepare
the cross section of G1C8 is illustrated on top-left of (f). Scale bar = 20 μm.
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Atomic force microscopy (AFM) was used to probe the surfaces of uniform films for
calculation of roughness. Nano-scale features were observed on PG surface (Fig. 3.5 (a)), with
an average root-mean-square roughness of 42 nm. Incorporation of chitosan notably increases
the roughness to 137 nm (Fig. 3.5 (b)), resulting in a grainy surface. It is interesting that this
composite approach changed the nano-structured surface of graphene, which will have
implications for subsequent cellular interactions. The topography of a silicon wafer was
characterized for comparison (Fig. 3.5 (c)).
3.2.3.4 Cytotoxicity of G
As mentioned earlier, cytotoxicity is one of the main concerns in the biomedical
applications of CNT, especially for single-wall CNT (SWCNT). Based on their extensive study,
Tian et al. attributed the toxic effect of SWCNT to its ultra-small dimensions.98 Since graphene
sheets are two-dimensional materials with micro-scale lateral length, a lower cytotoxicity
comparing to CNTs is possible. Compared to the reported 75% survival rate of human fibroblast
cells (2-day treatment of SWCNT: 25 μg/mL),98 a 92.8% survival rate for the same type of cell
(2-day treatment of graphene: 25 μg/mL) was observed in our study (Fig. 3.6). Graphene also
showed high biocompatibility to neuron cells (N2a) with a 93.3% survival rate. The results
suggest good cytocompatibility of graphene towards both fibroblasts and neurons and suitable
for further investigation for neural interfaces. A recently published article also demonstrates a
better biocompatibility of graphene compared with CNTs.91
3.2.3.5 Neuronal responses to G-C
Besides electrical properties, good interaction between biomaterials and neurons is
particularly desired for neural interface applications. Ideally, the material should support neuron
adhesion and growth to ensure high fidelity and maximal signal communication between the
implant and the nervous system.
For both the N2a neural cell line and primary chick cortical neurons, PG was not
favorable for cell adhesion (Fig. 3.7), which could be attributed to the presence of negatively
charged sulfonate groups on graphene (Fig. 3.2). However, some G-C nanocomposites showed
much higher cell attachment (G1C4 for N2a; G1C4 and G1C8 for cortical neuron), suggesting
that incorporation of amine-rich chitosan improves the material’s ability to support neuron
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Figure 3.5 AFM images showing the surface topography of samples: (a) PG, (b) G1C8, and (c) silicon
wafer. Scale bar = 20 μm.
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Figure 3.6 Cytotoxicity of graphene (G) showing high survival rate of cells: fibroblast (NIH 3T3 92.8%)
and neurons (N2a, 93.3%). Cells were treated with 25 μg/mL of graphene (G+) for 2 days. Control
sample without graphene treatment is noted as G (-). The survival rate of fibroblast (75%) with carbon
nanotubes (CNTs) treatment is presented for comparison.98
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Figure 3.7 Cell adhesion of N2a cell line and primary cortical neuron expressed as percentage to the
poly(L-lysine) (PLL) positive control. N2a: G1C4 is significantly higher than other samples; Cortical
neuron: G1C4 and G1C8 are significantly higher than other samples. (n = 3, p < 0.05).
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adhesion. The responses of N2a and cortical neuron to this series of G-C composites are slightly
different. For example, it appears G1C1 supported more N2a cells, while G1C8 supported more
cortical neuron. This observation could be attributed to the different characteristics of the two
types of cells.
According to the results from cell adhesion study, the morphology of cortical neuron on
PG, G1C4, and G1C8 were investigated by SEM. Extensive neurite-like structures were
observed stemming from the body of cortical neurons attached on G-C nanocomposite (Fig. 3.8
(a)). This suggests the potential ability of the G-C nanocomposites to induce neural
differentiation. It appears as if the surface roughness of the G-C nanocomposites allows for
extensive neurite formation (Fig 3.8 (b) – (d) arrows). The intimate contact between neurons
and G-C surface is advantageous for neural interface applications. It can not only improve
neuron adhesive strength to the implanted device and therefore minimize micromotion between
the device and the tissue, but also promote signal transduction between the attached neuron and
the device. This could lead to enhanced sensitivity of the device. Though PG in general is not
pro-neural adhesion, those few cells that did attach were seen with neurite-like structures as well
(Fig. 3.8 (e)). The morphology of neural processes was very different from those on the G-C
surface. The neurites were much fewer in numbers, but they were longer and showed extensive
branching (Fig. 3.8 (f)). It is as if the cells are trying to maximize the anchoring points with the
relatively featureless surface. The long neurites are also beneficial for neural interface
applications, as they will allow cell-cell communication. Studies have shown that both microand nano-scale topography of the substrates could have influence on cell migration, adhesion,
differentiation, and morphology.104 Although the underlying mechanism remains elusive, the
different topographic properties of PG and G-C nanocomposites could account for the different
cell morphologies observed in this study. Both morphologies are intriguing and we are interested
to further tune the G-C compositions to develop a material that can enable development of both
types of neural processes for interfacing.

3.3 Conclusions
We reported for the first time the development of a simple G-C nanocomposite system
for potential neural interface applications. The G-C nanocomposites can be prepared both as
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Figure 3.8 SEM images of primary cortical neuron growing on samples: (a-d) G1C8 and (e, f) PG films
with different neurite-like structures (arrows).
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coatings and flexible free-standing films simply from environmentally and biologically friendly
aqueous dispersions of water soluble graphene and chitosan. The free standing films showed
good flexibility and capability for insertion. The electrical conductivity of graphene was
maintained in the composite system. Cytotoxicity study showed good biocompatibility of
graphene towards both fibroblast and neuron. The bio-adhesive property of chitosan was
reassured in this study. The morphology of the films was closely dependent on the composition,
and directly influenced neuron adhesion and morphology. This biocompatible G-C
nanocomposite system is poised for further development and investigation as a novel implantable
material to advance neural interface technologies. It could also provide a new platform for in
vitro neurophysiology study.
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CHAPTER IV
GENERAL CONCLUSIONS AND FUTURE PERSPECTIVES
The ability of chitosan to enhance neuron adhesion was confirmed by the two studies in
Chapter II and Chapter III. In respect of the cell morphology, the influences from chitosan were
mainly composition dependent:
For the C-A hydrogel system, chitosan was embedded in the scaffold matrix and served
as anchorage points for neurite extension. An optimum concentration range of chitosan was
found to induce the best neural network compared with other compositions. Neither too low nor
too high composition of chitosan could support good neurite outgrowth. A “steric hindrance”
effect was proposed to explain the observations, and could be used as a simple yet versatile
approach to obtain desirable neuronal structures.
For the G-C nanocomposite film system, the introduction of chitosan affected neuron
morphology in another way. A rougher surface with nano-scale features was found for G-C
nanocomposite films compared with plain graphene film, likely due to the incorporation of
chitosan. Neurons displayed totally different structures on these two types of substrates. The
underlying mechanism for this observation is still elusive, but it implies the possibility to tune
the topological features of the G-C nanocomposites by simply adjusting the chitosan
composition, and eventually control the interaction between neuron and substrates.
To maximize the clinical potential of the C-A hydrogel system, it is important to improve
the gelation condition near physiological value. It could be accomplished by either incorporating
an enzymatically induced gelation mechanism or tweaking agarose gelation temperature to that
near physiological value. Concerns over the slow degradation of agarose and chitosan can be
addressed by introducing moieties that allow for controlled release of degradative enzymes
without interfering with the function of the gel. Future studies can also include embedding
clinically relevant, traumatized neurons prepared with techniques reported by vandenPol et al.105
within the gel and investigating cell-gel interaction, cell-cell interaction, and cell migration in
three dimensions.
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Although the study for G-C nanocomposites provides promising results, more in-depth
works need to be done in the future. As implanted materials, the mechanical properties, of the
film (e.g., contact stiffness, tensile strength, etc.) should be quantitatively measured and the
biostability of the film needs to be determined under physiological conditions. The compositions
and fabrications of free-standing films should also be optimized for the best neuron-material
interaction. A study to determine the capability of G-C nanocomposite to electrically interface
with neuron would be informative. Responses of other types of cells in the brain towards G-C
films, such as astrocyte and microglia, should also be investigated. Finally, for practical
applications, in vivo study should be conducted to investigate the host response to G-C
nanocomposite.
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